CXXC5 and myelodysplastic syndrome: The chromosomal location of the CXXC5 gene (5q31.2) is a frequently deleted region in AML/MDS patients, which implicates that haploinsufficiency or functional defects in CXXC5 may be involved in the development of AML/MDS [12, 13].